As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a ‘free’ updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

India potassium clavulanate market is expected to grow at a steady rate during the forecast period. The India potassium clavulanate market is driven by mounting incidence of acute bacterial sinusitis infection in the country.  Moreover, this drug API can be taken by all age groups which is forecasted to positively influence the market growth. Ongoing research and developmental activities by key market players is further expected to boost the growth of India potassium clavulanate market through FY2026.

The India potassium clavulanate market is segmented based on composition, route of administration, form, distribution channel, source, application, end user, company, and region. Based on application, the market can be segmented into respiratory tract infections, skin infections, UTI, otitis media, gynaecological infections, bone and joint infections and others. Among these, respiratory infections segment is expected to dominate the market in the coming years on account of high growth in the number of people having respiratory disorders. Also, the effective use of this drug for the treatment of pneumonia is expected to drive this segmental growth in the years to come.

The major players operating in the India potassium clavulanate market are MacLeod’s Pharmaceuticals Ltd.., Hetero Healthcare Ltd., HLL Lifecare Ltd., Novartis India Ltd. (Sandoz), Modi Mundipharma Ltd., Ikon Remedies Pvt. Ltd., Glenmark Pharmaceuticals Ltd., Elkos Healthcare Pvt. Ltd., Lupin Laboratories Ltd., Zee Laboratories Ltd., and others. Major companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, research collaborations and new product developments to expand their geographic reach and to increase their customer basis.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India potassium clavulanate market from FY2016 to FY2019.
  • To estimate and forecast the market size of India potassium clavulanate market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India potassium clavulanate market based on composition, route of administration, form, distribution channel, source, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the India potassium clavulanate market.
  • To identify drivers and challenges for India potassium clavulanate market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India potassium clavulanate market.
  • To identify and analyze the profile of leading players operating in India potassium clavulanate market.
  • To identify key sustainable strategies adopted by market players in India potassium clavulanate market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India potassium clavulanate market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Potassium clavulanate manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to potassium clavulanate

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India potassium clavulanate market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Potassium Clavulanate Market, By Composition:
    • Single
    • Combinational
  • India Potassium Clavulanate Market, By Route of Administration:
    • Oral
    • Intravenous
  • India Potassium Clavulanate Market, By Form:
    • Tablet
    • Capsule
    • Syrup
    • Injection
  • India Potassium Clavulanate Market, By Distribution Channel:
    • Online
    • Offline
  • India Potassium Clavulanate Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Potassium Clavulanate Market, By Application:
    • Respiratory Tract Infections
    • Skin Infections
    • UTI
    • Otitis media
    • Gynaecological infections
    • Bone and Joint Infections
    • Others
  • India Potassium Clavulanate Market, By End User:
    • Adult
    • Paediatric
  • India Potassium Clavulanate Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India potassium clavulanate market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India potassium clavulanate market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Potassium Clavulanate Market

4.    Executive Summary

5.    Manufacturing Potassium Clavulanate

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Potassium Clavulanate

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Potassium Clavulanate Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Composition (Single, Combinational)

7.2.2.     By Route of Administration (Oral v/s Intravenous)

7.2.3.     By Form (Tablet, Capsule, Syrup, Injection)

7.2.4.     By Distribution Channel (Online v/s Offline)

7.2.5.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.6.     By Application (Respiratory Tract Infections, Skin Infections, UTI, Otitis media, Gynaecological infections, Bone and Joint Infections and Others)

7.2.7.     By End User (Adult v/s Pediatric)

7.2.8.     By Region (North, East, South, West)

7.2.9.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  MacLeod’s Pharmaceuticals Ltd.

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  Hetero Healthcare Ltd.

14.1.3.  HLL Lifecare Ltd.

14.1.4.  Novartis India Ltd. (Sandoz)

14.1.5.  Modi Mundipharma Ltd.

14.1.6.  Ikon Remedies Pvt. Ltd.

14.1.7.  Glenmark Pharmaceuticals Ltd.

14.1.8.  Elkos Healthcare Pvt. Ltd.

14.1.9.  Lupin Laboratories Ltd.

14.1.10.                Zee Laboratories Ltd.

15.  Strategic Recommendations

About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com